In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Anamorelin is a drug that mimics the function of ghrelin in the human body, whic···【more】
Release date:2024-08-22Recommended:164
Koselugo is a carefully developed small molecule MEK inhibitor (also known as a ···【more】
Release date:2024-08-22Recommended:217
Koselugo is a class of finely designed small molecule MEK blockers (also known a···【more】
Release date:2024-08-22Recommended:212
Koselugo is a precisely targeted small molecule MEK inhibitor with a therapeutic···【more】
Release date:2024-08-22Recommended:235
Koselugo is a class of precision small molecule MEK inhibitors (also regarded as···【more】
Release date:2024-08-22Recommended:187
Koselugo is a small molecule MEK inhibitor (figogen activation inhibitor) that i···【more】
Release date:2024-08-22Recommended:188
Anamorelin is a drug for cancer cachexia that increases a patient's appetite···【more】
Release date:2024-08-21Recommended:237
As a selective ghrelin receptor agonist, anamolin is approved in Japan for impro···【more】
Release date:2024-08-21Recommended:179
Through its unique pharmacological effects, Anamoreline is effective in helping ···【more】
Release date:2024-08-21Recommended:152
Anamorelin helps cancer patients with dyscrasia restore the body's energy su···【more】
Release date:2024-08-21Recommended:197
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by vario···【more】
Release date:2024-08-21Recommended:234
Anamorelin is a novel ghrelin receptor agonist specifically designed for the tre···【more】
Release date:2024-08-21Recommended:300